MedTrace Logo

Incremental PD With Single Icodextrin Exchange

NCT06119373 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2023-11-08

No results posted yet for this study

Summary

Objectives: To investigate the efficacy and safety of single daily icodextrin exchange for initiation of incremental peritoneal dialysis (PD).

Subjects: Seventy-two incident PD patients.

Methods: A single-center randomized controlled trial.

Primary outcome: Change in residual kidney function in 48 weeks after recruitment.

Conditions

  • Peritoneal Dialysis Complication
  • Residual Kidney Function
  • Survival
  • Health-related Quality of Life

Interventions

OTHER

Single daily icodextrin exchange

PD initiation with single daily exchange of 2-liter icodextrin-based dialysis solution.

OTHER

Conventional PD group

PD is initiated with 2 to 3 exchanges of 2-liter glucose-based dialysis solution.

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Wei Fang, MD., PhD. · RenJi Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-01
Primary Completion
2026-05-31
Completion
2026-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06119373 on ClinicalTrials.gov